Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
20.92
-0.33 (-1.55%)
Sep 29, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Employees
Pelthos Therapeutics had 92 employees as of December 31, 2025. The number of employees increased by 81 or 736.36% compared to the previous year.
Employees
92
Change (1Y)
81
Growth (1Y)
736.36%
Revenue / Employee
$470,696
Profits / Employee
-$939,043
Market Cap
80.09M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 92 | 81 | 736.36% | 92 | 0 |
| Dec 31, 2024 | 11 | 3 | 37.50% | 4 | 7 |
| Dec 31, 2023 | 8 | 6 | 300.00% | 4 | 4 |
| Sep 30, 2023 | 3 | 0 | - | 3 | 0 |
| Dec 31, 2022 | 2 | 0 | - | 2 | 0 |
| Sep 30, 2022 | 3 | 1 | 50.00% | 3 | 0 |
| Jun 30, 2022 | 3 | - | - | 3 | 0 |
| Dec 31, 2021 | 2 | - | - | 2 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Fractyl Health | 100 |
| Verrica Pharmaceuticals | 76 |
| Acrivon Therapeutics | 76 |
| Oncolytics Biotech | 29 |
| iBio, Inc. | 23 |
| Gain Therapeutics | 21 |
| Cognition Therapeutics | 14 |
| Atara Biotherapeutics | 10 |
PTHS News
- 6 weeks ago - Pelthos Therapeutics Proxy statement: Proxy filing - Filings
- 6 weeks ago - Pelthos Therapeutics Proxy statement: Proxy filing - Filings
- 6 weeks ago - Pelthos Therapeutics price target lowered to $45 from $75 at Alliance Global - TheFly
- 6 weeks ago - Pelthos Therapeutics price target lowered to $64 from $66 at Oppenheimer - TheFly
- 6 weeks ago - Pelthos Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - Pelthos Therapeutics Earnings release: Q2 2026 - Filings
- 6 weeks ago - Pelthos Therapeutics Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Pelthos Therapeutics Slides: Corporate presentation - Filings